Unbiased quantitative assessment of Her-2 expression of circulating tumor cells in patients with metastatic and non-metastatic breast cancer

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

(2012) Linda Sofie Lindström et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study

(2012) Jean-Yves Pierga et al.   LANCET ONCOLOGY

High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

(2011) J.- Y. Pierga et al.   ANNALS OF ONCOLOGY

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient Care

(2011) A. Fabi et al.   CLINICAL CANCER RESEARCH

Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival

(2011) Sjoerd T. Ligthart et al.   PLoS One

FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform

(2011) Julie Ann Mayer et al.   Cancer Genetics

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

(2010) F.- C. Bidard et al.   ANNALS OF ONCOLOGY

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer

(2010) F. A. W. Coumans et al.   ANNALS OF ONCOLOGY

Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

(2010) S. Riethdorf et al.   CLINICAL CANCER RESEARCH

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

(2009) Minetta C. Liu et al.   JOURNAL OF CLINICAL ONCOLOGY

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer

(2009) Seigo Nakamura et al.   Breast Cancer

Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications

(2007) F. Nole et al.   ANNALS OF ONCOLOGY